ADPT
Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp (ADPT) Insider Trading
42 transactions reported on SEC Form 4 — executive and director buys and sells.
Buys
0
Sells
24
Net value
$-25.5M
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| RUBINSTEIN JULIE | President and COO | Sell | 11,581 | $280.4K | 1d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 3d ago |
| RUBINSTEIN JULIE | President and COO | Sell | 6,781 | $173.4K | 3d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 2d ago |
| RUBINSTEIN JULIE | President and COO | Sell | 11,881 | $304.3K | 2d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 1d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 8d ago |
| RUBINSTEIN JULIE | President and COO | Sell | 11,881 | $303.0K | 4d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 4d ago |
| RUBINSTEIN JULIE | President and COO | Sell | 9,181 | $232.7K | 5d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 5d ago |
| RUBINSTEIN JULIE | President and COO | Sell | 11,881 | $313.8K | 8d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 10d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 9d ago |
| RUBINSTEIN JULIE | President and COO | Sell | 11,881 | $304.9K | 9d ago |
| BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 6,444 | $193.3K | 11d ago |
| RUBINSTEIN JULIE | President and COO | Exercise | 11,881 | $144.2K | 11d ago |
| RUBINSTEIN JULIE | President and COO | Sell | 9,381 | $256.7K | 11d ago |
| RUBINSTEIN JULIE | President and COO | Sell | 11,881 | $313.7K | 10d ago |
| LO FRANCIS | Chief People Officer | Sell | 107,537 | $3.0M | Sep 16, 2026 |
| LO FRANCIS | Chief People Officer | Exercise | 53,091 | $644.5K | Sep 16, 2026 |
| OWEN KATEY EINTERZ | Gift | 12,539 | — | Aug 31, 2026 | |
| BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 3,000 | $75.0K | Aug 10, 2026 |
| ROBINS HARLAN S | Chief Scientific Officer | Sell | 278,698 | $6.1M | Jul 21, 2026 |
| ROBINS HARLAN S | Chief Scientific Officer | Exercise | 284,800 | $1.9M | Jul 21, 2026 |
| BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 5,000 | $115.0K | Jul 16, 2026 |
| LO FRANCIS | Chief People Officer | Sell | 105,762 | $2.4M | Jul 15, 2026 |
| LO FRANCIS | Chief People Officer | Exercise | 59,374 | $463.1K | Jul 15, 2026 |
| ROBINS HARLAN S | Chief Scientific Officer | Sell | 239,351 | $5.2M | Jul 2, 2026 |
| BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 487 | $10.7K | Jul 1, 2026 |
| LO FRANCIS | Chief People Officer | Exercise | 12,626 | $98.5K | Jul 2, 2026 |
| LO FRANCIS | Chief People Officer | Exercise | 3,500 | $27.3K | Jul 1, 2026 |
| LO FRANCIS | Chief People Officer | Sell | 8,743 | $193.9K | Jul 1, 2026 |
| LO FRANCIS | Chief People Officer | Sell | 44,838 | $1.0M | Jul 2, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 11,034 | $231.7K | Jun 26, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Exercise | 11,034 | $134.0K | Jun 26, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 154,768 | $3.3M | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Exercise | 1,837 | $22.3K | Jun 29, 2026 |
| GRIFFIN MICHELLE RENEE | Exercise | 52,084 | $406.3K | Jun 25, 2026 | |
| GRIFFIN MICHELLE RENEE | Sell | 52,084 | $1.1M | Jun 25, 2026 | |
| BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 5,000 | $102.5K | Jun 25, 2026 |
| BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 5,000 | $95.0K | Jun 11, 2026 |